Copley Scientific Launches New Equipment to Streamline Inhaled Product Testing
Copley Scientific has launched a new instrument, the TPK-R critical flow controller model to improve the ergonomics of test set-up for dry powder inhaler (DPI) testing. The new unit frees up bench-space and simplifies connection of the key pieces of equipment routinely used for DPI testing, without compromising the validity of existing test methods.
Measuring the aerodynamic particle size distribution of DPIs helps to determine their in vivo behaviour and is essential during product development and for QC. Cascade impaction is the technique specified by the regulators, and the Next Generation Impactor (NGI) is routinely the instrument of choice for this application. Testing must be carried out at a constant, controlled air flow rate to ensure that the NGI delivers precise, calibrated performance.
Copley Scientific’s TPK Critical Flow Controllers incorporate all the functionality required to ensure the application of a stable, precisely defined flow profile, in a single integrated system. The TPK-R is a mirror image of the Critical Flow Controller Model TPK, which is already an industry standard, and has been designed specifically to match with the connection requirements of the NGI. It is identical to the TPK in all respects except for the inlet, outlet and user interfaces, which have all been reversed to connect more conveniently with the right-hand outlet of the NGI. Using the TPK-R therefore allows the more efficient use of laboratory bench space, without compromising the validity of existing test methods.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance